Paper36738367
An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.
Upadhayay S and 11 others. Neurochem Res, 2023. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development. Papers, record 36738367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36738367
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Huntington Disease | Major topic |
| Animals | |
| Neurotoxins | |
| Disease Models, Animal | |
| Nitro Compounds | |
| Propionates | |
| Drug Discovery |
Source PubMed
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,833,174 | Hippocampal dysfunction defines disease onset in Huntington's disease. | J Neurol Neurosurg Psychiatry | 2016 | https://conductscience.org/library/papers/26833174 | PubMed |
| 2 | 17,572,452 | Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. | Physiol Behav | 2007 | https://conductscience.org/library/papers/17572452 | PubMed |
| 3 | 22,154,757 | Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. | Eur J Pharmacol | 2012 | https://conductscience.org/library/papers/22154757 | PubMed |
| 4 | 8,593,585 | Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. | Brain Res | 1995 | https://conductscience.org/library/papers/8593585 | PubMed |
| 5 | 8,837,046 | Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. | Neurochem Int | 1996 | https://conductscience.org/library/papers/8837046 | PubMed |
| 6 | 32,796,930 | Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. | Nat Rev Neurol | 2020 | https://conductscience.org/library/papers/32796930 | PubMed |
| 7 | 30,054,774 | Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway. | Metab Brain Dis | 2018 | https://conductscience.org/library/papers/30054774 | PubMed |
| 8 | 30,260,985 | Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease. | PLoS One | 2018 | https://conductscience.org/library/papers/30260985 | PubMed |
| 9 | 3,629 | Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. | J Neurochem | 1976 | https://conductscience.org/library/papers/3629 | PubMed |
| 10 | 18,093,658 | Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. | Neurotoxicology | 2008 | https://conductscience.org/library/papers/18093658 | PubMed |
| 11 | 27,011,624 | The story of George Huntington and his disease. | Ann Indian Acad Neurol | 2016 | https://conductscience.org/library/papers/27011624 | PubMed |
| 12 | 7,629,905 | Moldy sugarcane poisoning--a case report with a brief review. | J Toxicol Clin Toxicol | 1995 | https://conductscience.org/library/papers/7629905 | PubMed |
| 13 | 19,927,170 | Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. | Neurosci Bull | 2009 | https://conductscience.org/library/papers/19927170 | PubMed |
| 14 | 19,627,208 | Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. | J Med Food | 2009 | https://conductscience.org/library/papers/19627208 | PubMed |
| 15 | 9,875,735 | Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. | Neuroreport | 1998 | https://conductscience.org/library/papers/9875735 | PubMed |
| 16 | 1,851,219 | Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. | J Neurosci | 1991 | https://conductscience.org/library/papers/1851219 | PubMed |
| 17 | 17,007,735 | Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. | Acta Pharmacol Sin | 2006 | https://conductscience.org/library/papers/17007735 | PubMed |
| 18 | 30,021,362 | Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30021362 | PubMed |
| 19 | 22,515,819 | Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke. | CNS Neurosci Ther | 2012 | https://conductscience.org/library/papers/22515819 | PubMed |
| 20 | 19,504,387 | Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. | J Asian Nat Prod Res | 2009 | https://conductscience.org/library/papers/19504387 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,616,200 | The potential of vitamins in Huntington's disease: bridging mechanistic evidence with translational limitations and future strategies. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42616200 | PubMed |
| 42,217,109 | 3-Nitropropionic Acid-Induced Huntington's Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42217109 | PubMed |
| 42,213,222 | Neuroprotective Potential of Pinostrobin in a Rat Model of Huntington's Disease: Behavioural, Biochemical, and Molecular Docking Evidence. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42213222 | PubMed |
| 41,870,813 | Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41870813 | PubMed |
| 41,762,337 | Roflumilast Elicits Therapeutic and Neuroprotective Effects in 3-Nitropropionic Acid-Induced Huntington's Disease-Like Neurodegeneration in Rats by Mitigating NLRP3 Inflammasome-Mediated Pyroptosis, Ferroptosis, and Glial Activation. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41762337 | PubMed |
| 41,276,654 | Anandamide-Induced Neuroprotection of Cortical Neurons Relies on Metabolic/Redox Regulation and Mitochondrial Dynamics. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41276654 | PubMed |
| 41,255,420 | A design-of-experiments strategy for engineering 3D topographical features in osteosarcoma modelling. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41255420 | PubMed |
| 40,956,543 | Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington's disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40956543 | PubMed |
| 40,867,512 | Progress on 3-Nitropropionic Acid Derivatives. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867512 | PubMed |
| 40,314,217 | The role of gut microbiota-mitochondria crosstalk in neurodegeneration: Underlying mechanisms and potential therapies. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40314217 | PubMed |
| 40,252,127 | Oxytocin Anti-Apoptotic Potential Mediates Neuroprotection Against 3-Nitropropionic Acid-Induced Huntington's Disease-Like Pathophysiology in Rats: Involvement of Calpain-2/p25 Cdk5/MEF-2 Signaling Pathway. | Neurochem Res | 2025 | https://conductscience.org/library/papers/40252127 | PubMed |
| 39,820,855 | Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates. | Neurogenetics | 2025 | https://conductscience.org/library/papers/39820855 | PubMed |
| 39,764,462 | A supercritical oil extract of Schisandra chinensis seeds ameliorates Huntington's disease-like symptoms and neuropathology: the potential role of anti-oxidant and anti-inflammatory effects. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39764462 | PubMed |
| 39,546,221 | Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/39546221 | PubMed |
| 39,414,701 | Glycosylation of chrysin with β-d-glucose tetraacetate (LQFM280) enhances its in vitro and in vivo neuroprotective effects against the toxicity induced by 3-nitropropionic acid. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39414701 | PubMed |
| 38,982,016 | Mitochondrial targeted antioxidants as potential therapy for huntington's disease. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38982016 | PubMed |
| 38,427,225 | TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/38427225 | PubMed |
| 38,372,755 | Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/38372755 | PubMed |
| 38,306,038 | Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38306038 | PubMed |
| 37,875,411 | [Research advances of porous organic framework materials on enrichment and detection of mycotoxins]. | Se Pu | 2023 | https://conductscience.org/library/papers/37875411 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36738367
GET https://conductscience.org/api/papers/v1/36738367/references?page=2